Aldesleukin
Overview
Categories
- 8 Antineoplastics, immunomodulators and drugs used in palliative care
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Aldesleukin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 18 to 18 Million Units | 18 (18) | 24 hourly | Sc | 18 million units given Subcutaneus once daily for 5 day, followed by 2 days rest for the first week. for the next 3 week 18 million uints on day 1 & 2 of each week and 9 million units on day 3 to 5 of each week followed by 2 week rest. This 4 week cycle may be repeated after an interval of 1 week. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Aldesleukin is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Aldesleukin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Aldesleukin
Back to top
Previous Drug Generic - Next Drug Generic